DTX PHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Feb 2026)
What this means for you
This application is over — abandoned 23 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97249797
- Mark type
- Stylized text
- Filed
- 02 Feb 2022
- Published for opposition
- 23 May 2023
- Abandoned
- 23 Feb 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, oligonucleotide compounds; oligonucleotide compounds for the treatment of genetic diseases; oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases; therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases; fatty acid-based oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development of oligonucleotide compounds; scientific research and product development in the field of oligonucleotide compounds and drug discovery; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in the treatment of genetic diseases; Pharmaceutical research and development of therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases
Owner
- DTx Pharma, Inc., San Diego, CA, US
- DTx Pharma, Inc., San Diego, CA, US
Prosecution history
- 23 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 4 GRANTED
- 14 Jul 2025 — SOU EXTENSION 4 FILED
- 14 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2025 — SOU EXTENSION 3 GRANTED
- 14 Jan 2025 — SOU EXTENSION 3 FILED
- 14 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2024 — SOU EXTENSION 2 GRANTED
- 11 Jul 2024 — SOU EXTENSION 2 FILED
- 11 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED